A systematic study of CSTD-generated stress on different biomolecular modalities.

John F Seeler1, Yongting Ma1, Vish Swami1

  • 1Drug Product and Device Development, Takeda Pharmaceutical Company, Lexington, MA, USA.

PubMed
Summary

Closed System Transfer Devices (CSTDs) can generate significant visible and subvisible particles, including protein and silicone oil, impacting biologic drug stability. Device fluid path geometry is a key factor in this particle formation.